Financing

Debt Issuance Proceeds

Year-over-year, this metric grew by 100.1%, from $3.99B to $7.99B. Over 4 years (FY 2021 to FY 2025), Debt Issuance Proceeds shows an upward trend with a 41.4% CAGR.

Analysis

StatementCash Flow Statement
SectionFinancing
CategoryLeverage
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026

How to read this metric

High issuance can signal expansion plans or a strategy to take advantage of low interest rates, but also increases future interest obligations.

Detailed definition

The total cash proceeds received from the sale of bonds, notes, or other debt instruments. This represents an increase i...

Peer comparison

Companies often issue debt even when they have cash to optimize their weighted average cost of capital (WACC).

Metric ID: debt_issuance

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$250.00M$250.00M$250.00M$2.00B$0.00$0.00$0.00$0.00$0.00$0.00$0.00$14.96B$0.00$0.00$2.00B$3.99B$0.00$0.00$0.00$7.99B
QoQ Change+0.0%+0.0%+700.0%-100.0%-100.0%+99.7%-100.0%
YoY Change-100.0%-100.0%-100.0%-100.0%-73.3%-100.0%+100.1%
Range$0.00$14.96B
CAGR+107.4%
Avg YoY Growth-67.6%
Median YoY Growth-100.0%

Frequently Asked Questions

What is AbbVie's debt issuance proceeds?
AbbVie (ABBV) reported debt issuance proceeds of $7.99B in Q1 2026.
How has AbbVie's debt issuance proceeds changed year-over-year?
AbbVie's debt issuance proceeds increased by 100.1% year-over-year, from $3.99B to $7.99B.
What is the long-term trend for AbbVie's debt issuance proceeds?
Over 4 years (2021 to 2025), AbbVie's debt issuance proceeds has grown at a 41.4% compound annual growth rate (CAGR), from $1.00B to $3.99B.
What does debt issuance proceeds mean?
The amount of new money a company borrowed by issuing bonds or taking out loans.